IGTP-led study identifies an epigenetic signature with prognostic value in metastatic thyroid cancer
Researchers from the Endocrine Tumours group, in collaboration with five university hospitals, have conducted the first comprehensive study of DNA methylation patterns in metastatic differentiated thyroid cancer (DTC). Published in the journal Thyroid, the study identifies an epigenetic signature comprising 156 CpG sites in primary tumours that could help stratify patients according to their risk of developing distant metastases.